Clinical Trial Update: Lenvatinib, Tislelizumab Combined with Gemcitabine and Cisplatin (GPLET) in the Treatment of Advanced Cholangiocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating a quadruple therapy regimen with lenvatinib, tislelizumab, gemcitabine, and cisplatin (GPLET) for advanced cholangiocarci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)
• LENVIMA (lenvatinib)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Advanced Cholangiocarcinoma | Phase 3 | Status: RECRUITING